Vaidya Sane Ayurved Laboratories Fair Value
Fair Value Analysis Export
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
MADHAVBAUG Fair Value Analysis — Data Sources & Coverage
Vaidya Sane Ayurved Laboratories financial data sources, valuation methods applied and sector benchmarks used — 2023 financial year. See MADHAVBAUG price book multiple to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is 3 years old (2023).
MADHAVBAUG vs Healthcare Sector Peers — P/E, P/B & Market Cap
Vaidya Sane Ayurved Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Par Drugs & Chemical | PAR | 8.09 | 1.06 | ₹113 |
| Accretion Pharmaceuticals | ACCPL | 16.94 | 2.55 | ₹115 |
| Jeena Sikho Lifecare | JSLL | 41.45 | 23.68 | ₹8,396 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sat Kartar Life | SATKARTAR | 32.1 | 6.11 | ₹320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.